Nandrolone decanoate
Clinical data | |
---|---|
Trade names | Deca-Durabolin, Deca-Durabol, Decaneurabol, Metadec, Retabolil |
Routes of administration | Intramuscular injection |
Identifiers | |
| |
CAS Number | 360-70-3 |
PubChem (CID) | 9677 |
ChemSpider | 9296 |
UNII | H45187T098 |
Chemical and physical data | |
Formula | C28H44O3 |
Molar mass | 428.66 g·mol−1 |
3D model (Jmol) | Interactive image |
| |
|
Nandrolone decanoate (USAN, BAN) (brand names Deca-Durabolin, Deca-Durabol, Decaneurabol, Metadec, Retabolil), or nandrolone decylate, also known as 19-nortestosterone 17β-decanoate or 17β-[(1-oxodecyl)oxy]estr-4-en-3-one, is a synthetic androgen and anabolic steroid and a nandrolone ester.[1][2][3] It was introduced in 1962.[4] Along with nandrolone phenylpropionate (NPP), nandrolone decanoate is one of the most widely used nandrolone esters, and is marketed in many countries throughout the world, including in the United States, Canada, and United Kingdom.[2][5] Both nandrolone decanoate and NPP are prodrugs of nandrolone.[6]
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–. ISBN 978-1-4757-2085-3.
- 1 2 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717. ISBN 978-3-88763-075-1.
- ↑ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
- ↑ Consolidated List of Products Whose Consumption And/or Sale Have Been Banned, Withdrawn, Severely Restricted Or Not Approved by Governments. United Nations Publications. 1983. pp. 153–154. ISBN 978-92-1-130230-1.
- ↑ Walter Sneader (23 June 2005). Drug Discovery: A History. John Wiley & Sons. pp. 206–. ISBN 978-0-471-89979-2.
- ↑ Wijnand HP, Bosch AM, Donker CW (1985). "Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers". Acta Endocrinol Suppl (Copenh). 271: 19–30. PMID 3865478.
Progestogens (and progestins) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPRMs | |||||||||||||||||||||||||||||||
Antiprogestogens | |||||||||||||||||||||||||||||||
See also: Androgens and antiandrogens • Estrogens and antiestrogens • Glucocorticoids and antiglucocorticoids • Mineralocorticoids and antimineralocorticoids • Gonadotropins and GnRH |
AR |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||||||
See also: Estrogenics • Glucocorticoidics • Mineralocorticoidics • Progestogenics • Steroid hormone metabolism modulators • List of androgens/anabolic steroids |
PR |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
mPRs (PAQRs) |
| ||||||||||
See also: Androgenics • Estrogenics • Glucocorticoidics • Mineralocorticoidics • Steroid hormone metabolism modulators |